Anúncio
Anúncio
EBS
Emergent Biosolutions, Inc.
13.94
USDPatrocinado
+0.79
+6.01%
07 de jan., 16:00 UTC -5
Encerrado
Pós-Mercado
13.91
-0.03
-0.22%
Relatórios de Lucros EBS
Rácio de surpresa positiva
EBS separação 21 de 40 últimas estimativas.
53%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$219.68M
/$0.11
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-4.94%
/-89.62%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+12.83%
/+120.00%
Emergent Biosolutions, Inc. earnings per share and revenue
On 29 de out. de 2025, EBS reported earnings of 1.06 USD per share (EPS) for Q3 25, beating the estimate of -0.12 USD, resulting in a 974.59% surprise. Revenue reached 231.10 milhão, compared to an expected 195.94 milhão, with a 17.94% difference. The market reacted with a +36.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of 0.11 USD, with revenue projected to reach 219.68 milhão USD, implying an diminuir of -89.62% EPS, and diminuir of -4.94% in Revenue from the last quarter.
FAQ
What were Emergent Biosolutions, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Emergent Biosolutions, Inc. reported EPS of $1.06, beating estimates by 974.59%, and revenue of $231.10M, 17.94% above expectations.
How did the market react to Emergent Biosolutions, Inc.'s Q3 2025 earnings?
The stock price moved up 36.6%, changed from $9.40 before the earnings release to $12.84 the day after.
When is Emergent Biosolutions, Inc. expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Emergent Biosolutions, Inc.'s next earnings report?
Based on 4
analistas, Emergent Biosolutions, Inc. is expected to report EPS of $0.11 and revenue of $219.68M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio